The efficacy of selective laser trabeculoplasty versus argon laser trabeculoplasty in pseudophakic glaucoma patients

Figures & data

Table 1 Basic characteristics

	ALT number of eyes = 30	SLT number of eyes = 22	P-value
Mean age (years)	71.90	71.95	0.981
Baseline IOP pre-laser	25.73	25.63	0.876
Sex (M/F)	14/16	11/11
Treated eye (OD/OS)	16/14	10/12
PXFG	8	7
Pigmentary glaucoma	1	2
POAG	14	9
OHT	7	4
Mild glaucoma	6	4
Moderate glaucoma	14	10
Severe glaucoma	10	8

Abbreviations: ALT, argon laser trabeculoplasty; SLT, selective laser trabeculoplasty; IOP, intraocular pressure; M, male; F, female; OD, oculus dexter (right eye); OS, oculus sinister (left eye); PXFG, pseudoexfoliation glaucoma; POAG, primary open-angle glaucoma; OHT, ocular hypertension.

Figure 1 Change in IOP at various time points.

Abbreviations: IOP, intraocular pressure; Pre, pretreatment; ALT, argon laser trabeculoplasty; SLT, selective laser trabeculoplasty.

Table 2 Mean intraocular pressure after treatment

Time point	ALT (±SD)	SLT (±SD)	Total patients (SLT and ALT) (n)	P-value*
Baseline	25.11 ± 2.16	25.36 ± 1.83	37	0.898
1 hour	23.94 ± 1.98	23.73 ± 2.15	37	0.763
1 week	22.66 ± 2.24	21.26 ± 2.35	37	0.072
1 month	22.31 ± 1.66	21.05 ± 2.65	33	0.117
3 months	22.25 ± 1.80	20.93 ± 2.11	32	0.069
6 months	21.37 ± 1.54	21.00 ± 2.52	28	0.638
12 months	21.88 (2.05)	21.06 (2.11)	33	0.269

Note:

* Significance set at P < 0.05.

Abbreviations: ALT, argon laser trabeculoplasty; SLT, selective laser trabeculoplasty; SD, standard deviation.

Table 3 Number of eyes that sustained adverse events

Complications	ALT (n = 8)	SLT (n = 3)
Trabeculectomy	8 (26.7%)	2 (9.09%)
Change (addition) to IOP-lowering medications	3 (10%)	1 (4.5%)
ALT repeated	1 (3.33%)

Abbreviations: ALT, argon laser trabeculoplasty; SLT, selective laser trabeculoplasty; IOP, intraocular pressure.